Clinical Researches

Advancements in radiotherapy immobilization for head and neck cancer patients have demonstrated that open-face mask designs perform on par with traditional closed facemasks, ensuring...

A new clinical trial assesses the benefits of combining ramucirumab with irinotecan for patients battling advanced or recurrent gastric cancer, particularly those who have...

Oral cancer survivors face a significant risk of developing additional malignancies, according to recent findings from a large-scale clinical trial.Study Overview and Patient DemographicsResearchers...

Primary care in Germany may soon incorporate social prescribing as a standard practice to address non-medical health issues, according to a new feasibility trial....

A recent clinical trial launched in Spring 2024 aims to improve care delivery for breast cancer patients by implementing early social and behavioral determinants...

The COVID-19 pandemic has significantly impacted the management and outcomes of hypertensive individuals in Hong Kong, revealing critical disruptions in healthcare services and their...

An international team of specialists has established new guidelines aimed at optimizing treatment outcomes for children suffering from juvenile dermatomyositis (JDM). This collaborative effort...

A novel approach to managing Neonatal Opioid Withdrawal Syndrome (NOWS) shows promise, as a recent clinical trial explores the benefits of stochastic vibro-tactile stimulation...

A groundbreaking community-based initiative, ExtraCECI, is set to enhance the quality of life for individuals living with HIV/AIDS in Ghana. This program emphasizes a...

A groundbreaking study from the PRO-TECT trial offers a telephone alternative for cancer patients to report symptoms, aiming to reduce disparities in symptom management....

A recent multicenter study in Ireland reveals that patients using walking boots immediately after ankle fracture surgery experience better functional outcomes and lower healthcare...

The European Medicines Agency (EMA) has compiled extensive feedback from various stakeholders regarding the ICH M11 technical specifications. Leading organizations such as EORTC, EFPIA,...

The European Medicines Agency (EMA) is navigating a wave of comprehensive feedback from global clinical research organizations and patient advocacy groups regarding its Draft...

The International Council for Harmonisation (ICH) is introducing the E6(R3) guidelines, marking a significant update to the global standards governing clinical trials. Effective from...

The Cancer Medicines Forum (CMF) convened its latest meeting on March 31, 2025, bringing together key stakeholders from leading European organizations. Hosted virtually via...